Results 151 to 160 of about 6,357 (207)

Optimizing Preoperative Anemia in Non-Metastatic Colorectal Cancer: A Systematic Review on Surgical Recovery and Outcomes. [PDF]

Cancers (Basel)
Tsokkou S, Konstantinidis I, Papakonstantinou M, Chatzikomnitsa P, Gkaitatzi AD, Liampou E, Fantakis A, Kolympa G, Toutziari E, Alexandrou D, Giakoustidis D, Bangeas P, Papadopoulos VN, Giakoustidis A.   +13 more
europepmc   +1 more source

Chemotherapy-Free Achievement of Minimal Residual Disease in a Jehovah's Witness Patient With Ph-Negative B-ALL. [PDF]

Am J Case Rep
Koilpillai S, Altaf R, El Barche Palmera A, Hassanein H, Carlan SJ.   +4 more
europepmc   +1 more source

Safety Profile of Roxadustat in Anemic Patients: A Meta-Analysis of 21 RCTs. [PDF]

Medeni Med J
Tanriverdi LH, Sarici A, Erkurt MA, Berktas HB.   +3 more
europepmc   +1 more source

Global research trends in renal anemia: a multidimensional bibliometric study. [PDF]

Ren Fail
Niu Y, Wang Y, Huo C, Fang Y.
europepmc   +1 more source

Effects of erythropoietin administration on allogeneic blood transfusion requirements in adults undergoing surgery: a systematic review and meta-analysis. [PDF]

Front Med (Lausanne)
Chen J, Liu B, Cao H, Tian T, He J.
europepmc   +1 more source

Out-of-Pocket Spending for Biologic Drugs After Biosimilar Competition for Medicare Patients.

JAMA Netw Open
Riegler JS, Kesselheim AS, Rome BN.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Epoetin alfa

Reactions Weekly, 2003
Oscar C. Johnson, Caroline Chebli, Albert J. Aboulafia   +2 more
  +5 more sources

Epoetin-alfa

Reactions Weekly, 2022
Michelle C. Simpson, Eric G. Schaefer
  +4 more sources

Targeted molecular mechanisms of epoetin alfa

Lung Cancer, 2003
Despite therapeutic improvements and ongoing efforts to develop more efficacious therapies, the majority of lung cancer patients face a poor prognosis. Therefore, the primary goal of current treatment is palliation, improvement and maintenance of quality of life (QOL), and (modest) prolongation of survival.
Langer, Corey J., Hirsch, Fred R., Cortés-Funes, Hernan, Sawyer, Stephen T., Thatcher, Nick   +4 more
openaire   +3 more sources

Efficacy of once-weekly epoetin alfa

Clinical Nephrology, 2004
Patients with end-stage renal disease requiring hemodialysis are frequently treated with epoetin alfa (recombinant human erythropoietin, rHuEPO) for anemia. The aim of this study was to determine whether successful management of anemia could be maintained by changing the dosing schedule of epoetin alfa from 2 or 3 times per week to once-weekly ...
P, Barre, H, Reichel, M G, Suranyi, C, Barth   +3 more
openaire   +2 more sources